New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congressIn Stockholm on March 23, 2026, BioArctic's AB (publ) (NASDAQ: BIOA B) shared that their partner Eisai unveiled fresh findings at the 2026 International Conference on Alzheimer's and Parkinson's Diseases in Copenhagen, Denmark from March 17-21.
